Introduction of oxazolidinones into peripheral artery, percutaneous approach

85816101 Introduction of destructive agent into peripheral nerves and plexi, percutaneous approach Commodity 85816102 Introduction of other therapeutic substance into peripheral nerves and plexi, percutaneous approach Commodity 85816103 Introduction of regional anesthetic into peripheral nerves and plexi, percutaneous approach Commodity 85816104 Introduction of local anesthetic into peripheral nerves and plexi, percutaneous approach Commodity 85816105 Introduction of anti-inflammatory into peripheral nerves and plexi, percutaneous approach Commodity 85816106 Introduction of vasopressor into peripheral artery, percutaneous approach Commodity 85816107 Introduction of other hormone into peripheral artery, percutaneous approach Commodity 85816108 Introduction of human b-type natriuretic peptide into peripheral artery, percutaneous approach Commodity 85816109 Introduction of insulin into peripheral artery, percutaneous approach Commodity 85816110 Introduction of destructive agent into peripheral artery, percutaneous approach Commodity 85816111 Introduction of antiarrhythmic into peripheral artery, percutaneous approach Commodity 85816112 Introduction of platelet inhibitor into peripheral artery, percutaneous approach Commodity 85816113 Introduction of analgesics, hypnotics, sedatives into peripheral artery, percutaneous approach Commodity 85816114 Introduction of other diagnostic substance into peripheral artery, percutaneous approach Commodity 85816115 Introduction of radioactive substance into peripheral artery, percutaneous approach Commodity 85816116 Introduction of blood brain barrier disruption substance into peripheral artery, percutaneous approach Commodity 85816117 Introduction of other therapeutic substance into peripheral artery, percutaneous approach Commodity 85816118 Introduction of intracirculatory anesthetic into peripheral artery, percutaneous approach Commodity 85816119 Introduction of electrolytic and water balance substance into peripheral artery, percutaneous approach Commodity 85816120 Introduction of nutritional substance into peripheral artery, percutaneous approach Commodity 85816121 Introduction of serum, toxoid and vaccine into peripheral artery, percutaneous approach Commodity 85816122 Introduction of anti-inflammatory into peripheral artery, percutaneous approach Commodity 85816123 Introduction of other anti-infective into peripheral artery, percutaneous approach Commodity 85816124 Introduction of oxazolidinones into peripheral artery, percutaneous approach You are here 85816125 Introduction of other thrombolytic into peripheral artery, percutaneous approach Commodity 85816126 Introduction of clofarabine into peripheral artery, percutaneous approach Commodity 85816127 Introduction of monoclonal antibody into peripheral artery, percutaneous approach Commodity 85816128 Introduction of other antineoplastic into peripheral artery, percutaneous approach Commodity 85816129 Introduction of low-dose interleukin-2 into peripheral artery, percutaneous approach Commodity 85816130 Introduction of high-dose interleukin-2 into peripheral artery, percutaneous approach Commodity 85816131 Introduction of immunosuppressive into peripheral artery, percutaneous approach Commodity 85816132 Introduction of immunostimulator into peripheral artery, percutaneous approach Commodity 85816133 Introduction of recombinant human-activated protein c into peripheral artery, percutaneous approach Commodity